BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37277571)

  • 21. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.
    Prasanna T; Karapetis CS; Roder D; Tie J; Padbury R; Price T; Wong R; Shapiro J; Nott L; Lee M; Chua YJ; Craft P; Piantadosi C; Sorich M; Gibbs P; Yip D
    Acta Oncol; 2018 Nov; 57(11):1438-1444. PubMed ID: 30035653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Metastatic Pattern in Patients Presenting With or Without Obstructing Colorectal Cancer: A Retrospective Observational Study of 2595 Patients.
    Boeding JRE; Ramphal W; Crolla RMPH; Gobardhan PD; Schreinemakers JMJ
    Ann Surg Oncol; 2020 Apr; 27(4):1048-1055. PubMed ID: 31823170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
    Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
    Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of peritoneal carcinomatosis from colorectal cancer: review of the literature.
    Vallicelli C; Cavaliere D; Catena F; Coccolini F; Ansaloni L; Poiasina E; Abongwa HK; De Simone B; Alberici L; Framarini M; Verdecchia GM
    Int J Colorectal Dis; 2014 Aug; 29(8):895-8. PubMed ID: 24915844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer.
    Heuvelings DJI; Wintjens AGWE; Moonen L; Engelen SME; de Hingh IHJT; Valkenburg-van Iersel LB; den Dulk M; Beckervordersandforth J; Thijssen SGM; Leunissen DJG; Stassen LPS; Keszthelyi D; Mujagic Z; Speel EM; Bouvy ND
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer.
    Huang CJ; Teng HW; Chien CC; Lin JK; Yang SH
    PLoS One; 2014; 8(6):e65117. PubMed ID: 23755178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
    Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
    World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
    Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
    Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
    Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
    Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
    Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
    Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "When and how are peritoneal metastases of colo-rectal origin treatable".
    Cortés-Guiral D; Alyami M
    Surg Oncol; 2022 Aug; 43():101775. PubMed ID: 35545480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node-independent liver metastasis in a model of metastatic colorectal cancer.
    Enquist IB; Good Z; Jubb AM; Fuh G; Wang X; Junttila MR; Jackson EL; Leong KG
    Nat Commun; 2014 Mar; 5():3530. PubMed ID: 24667486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic evolution and diverse models of systemic metastases in colorectal cancer.
    Chen HN; Shu Y; Liao F; Liao X; Zhang H; Qin Y; Wang Z; Luo M; Liu Q; Xue Z; Cao M; Zhang S; Zhang WH; Hou Q; Xia X; Luo H; Zhang Y; Yang L; Hu JK; Fu X; Liu B; Hu H; Huang C; Peng Y; Cheng W; Dai L; Yang L; Zhang W; Dong B; Li Y; Wei Y; Xu H; Zhou ZG
    Gut; 2022 Feb; 71(2):322-332. PubMed ID: 33632712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
    Kobayashi H; Kotake K; Funahashi K; Hase K; Hirata K; Iiai T; Kameoka S; Kanemitsu Y; Maeda K; Murata A; Ohue M; Shirouzu K; Takahashi K; Watanabe T; Yano H; Yatsuoka T; Hashiguchi Y; Sugihara K;
    J Gastroenterol; 2014 Apr; 49(4):646-54. PubMed ID: 23793379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.
    Behrenbruch C; Hollande F; Thomson B; Michael M; Warrier SK; Lynch C; Heriot A
    ANZ J Surg; 2017 Sep; 87(9):665-670. PubMed ID: 28664645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    Stelzner S; Radulova-Mauersberger O; Zschuppe E; Kittner T; Abolmaali N; Puffer E; Zimmer J; Witzigmann H
    J Surg Oncol; 2019 Sep; 120(3):438-445. PubMed ID: 31168858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
    BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Poulsen TS; Høgdall E; Pfeiffer P; Jensen BV; Yilmaz MK; Nielsen D
    Acta Oncol; 2018 Aug; 57(8):1057-1062. PubMed ID: 29380640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.